NEW YORK, December 28, 2025, 23:38 ET — Market closed
- Altria shares closed down 2.34% at $57.60 on Friday. [1]
- The Marlboro maker traded ex-dividend for a $1.06 quarterly payout due Jan. 9. [2]
- Investors head into Monday watching for a post-dividend bounce, late-January results timing, and new filings in the Juul/NJOY patent case. [3]
Altria Group shares ended Friday down 2.34% at $57.60, underperforming a flat-to-lower U.S. market as the stock traded ex-dividend, Investing.com data showed. [4]
The move matters now because Altria is held largely for income, and dividend-related trading can distort the tape into year-end, when liquidity is thinner and positioning shifts quickly.
It also matters because Altria’s payout is large enough to account for much of a one-day swing. The company’s $1.06 quarterly dividend implies an annual yield of about 7.4% at Friday’s close, keeping the stock in focus for yield buyers. [5]
Altria said on Dec. 10 its board declared the $1.06 dividend payable on Jan. 9 to shareholders of record as of Dec. 26, with an ex-dividend date of Dec. 26. “Ex-dividend” means buyers after that date do not receive the upcoming payment. [6]
The shares fell $1.38 from their Dec. 24 close of $58.98, while the dividend itself is $1.06 — suggesting the bulk of the decline reflected the mechanical dividend adjustment. [7]
Trading was choppy on the day, with Altria ranging from $57.40 to $58.08 on volume of about 9 million shares, Investing.com data showed. [8]
In the tobacco group, Philip Morris was down about 1% in late Friday trade, while British American Tobacco was little changed, market data showed.
Investors are also tracking litigation tied to Altria’s push beyond cigarettes, particularly in vaping. In filings submitted Dec. 24 in Arizona federal court, Juul asked a judge to block Altria and its NJOY unit from using records Juul said were inadvertently published in a University of California, San Francisco database, while NJOY opposed the request, according to reports citing the joint discovery dispute statement. [9]
The dispute sits inside a broader patent fight between Juul and NJOY/Altria over e-vapor technology, with related matters spanning federal court and the U.S. International Trade Commission, Nicotine Insider reported. [10]
Management transition is another overhang investors have flagged. Altria said earlier this month CEO Billy Gifford will retire in May 2026 and CFO Salvatore Mancuso will succeed him; board chair Kathryn McQuade said, “We believe Sal has deep industry knowledge, a keen understanding of Altria’s challenges and opportunities, and a commitment to our 2028 enterprise goals.” [11]
Before the next session, traders will watch whether Altria steadies after the dividend reset, with the Jan. 9 payment date approaching for holders of record as of Dec. 26. [12]
Late January is the next key waypoint for fundamentals. MarketScreener lists Jan. 28 as a projected date for Altria’s fourth-quarter earnings release, while MarketBeat estimates Jan. 29. [13]
Altria narrowed its 2025 full-year adjusted diluted EPS guidance to $5.37 to $5.45 in its third-quarter update, and investors will look for the company’s 2026 outlook and any changes in its smoke-free strategy. [14]
Technicians are watching the recent band: Friday’s low near $57.40 as a first support area and the $59 region — roughly where the stock closed before the holiday — as a nearby resistance zone. [15]
References
1. www.investing.com, 2. investor.altria.com, 3. nicotineinsider.com, 4. www.investing.com, 5. investor.altria.com, 6. investor.altria.com, 7. www.investing.com, 8. www.investing.com, 9. news.bloomberglaw.com, 10. nicotineinsider.com, 11. www.reuters.com, 12. investor.altria.com, 13. www.marketscreener.com, 14. investor.altria.com, 15. www.investing.com
